Eagle Hit With Double Whammy On Vasopressin ANDA Product

ANDA Filer Eagle Has Previously Suggested Launching ‘At Risk’

 
• By Dean Rudge
  
Setback
Eagle has quickly seen a trial date shift from January to July, in addition to the CRL. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products